Individualized according to a person's specific mutated cancer cell. They address cancers already identified and treated, to prevent recurrence - the great fear of cancer patients. Such vaccines target key mutations in a given patient's cancer.

This creates a powerful immune response against that cancer - far more so than any previous attempts at creating cancer vaccines. The vaccine is able to attack the cancer much like a vaccine targets viral antigens.

This particular small study used melanoma patients but is only one of a class of many similar on-going studies. All are models for future RNA or DNA vaccines.

Thought to be able to be in general use within as little as five years.

Interesting that the companies behind developing the foremost COVID vaccines are developing this. approach. Seems gene sequencing is something they have special knowhow in.


personalized cancer vaccines - act against cancer "neoantigens" as against virus antigens

Interesting article. Thanks for sharing it!